FMP
Cyclo Therapeutics, Inc.
CYTH
NASDAQ
Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo for the treatment of Alzheimer's disease. In addition, it sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is based in Gainesville, Florida.
1.3 USD
0.07 (5.38%)
About
ceo
Mr. N. Scott Fine
sector
Healthcare
industry
Drug Manufacturers - Specialty & Generic
website
https://www.cyclotherapeutics.com
exchange
NASDAQ
Description
Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo for the treatment of Alzheimer's disease. In addition, it sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated...
CIK
0000922247
ISIN
US23254X2018
CUSIP
550241103
Address
6714 NW 16th Street
Phone
386 418 8060
Country
US
Employee
8
IPO Date
May 3, 2000
Summary
CIK
0000922247
Exchange
NASDAQ
Industry
Drug Manufacturers -...
Sector
Healthcare
CUSIP
550241103
ISIN
US23254X2018
Country
US
Price
1.3
Beta
-0.15
Volume Avg.
108.01k
Market Cap
37.33M
Shares
-
52-Week
0.83-2.57
DCF
0
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-1.06
P/B
-
Website
https://www.cyclotherapeutics.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest CYTH News
It looks like there's no news available.
